Gerresheimer acquires Sensile Medical for up to EUR 350M

Gerresheimer is acquiring Swiss technology company Sensile Medical AG for a maximum purchase price of EUR 350 million, with an initial payment of EUR 175 million. The acquisition extends Gerresheimer's business model toward OEM drug delivery platforms with digital and electronic capabilities.

“With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.”gerresheimer.com

• 2 sources
• gerresheimer.comGerresheimer extends business model and increases growth forecastJul 11, 2018
• dcatvci.orgGerresheimer To Acquire Sensile Medical for $409 Million - DCAT Value Chain InsightsEugeneAug 1, 2018

Summarized from public sources; check the original articles before acting on it.